Cargando…

Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes

Type 2 diabetes mellitus (T2DM) is a chronic metabolic abnormality leading to microvascular and macrovascular complications. Non-insulin Incretin mimic synthetic peptide exendin-4 was introduced as an anti-diabetic drug which helped diabetic patients with triggering insulin secretion; further resear...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajabi, Hadi, Ahmadi, Mahdi, Aslani, Somayeh, Saberianpour, Shirin, Rahbarghazi, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106955/
https://www.ncbi.nlm.nih.gov/pubmed/35620334
http://dx.doi.org/10.34172/apb.2022.025